Premium
Hyperamylasemia with papillary serous cystadenocarcinoma of the ovary
Author(s) -
Hayakawa Tetsuo,
Kameya Aklra,
Mizuno Ribun,
Noda Aljl,
Kondo Takaharu,
Hirabayashi Norio
Publication year - 1984
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19841015)54:8<1662::aid-cncr2820540829>3.0.co;2-u
Subject(s) - hyperamylasemia , medicine , serous cystadenocarcinoma , pathology , mucinous cystadenocarcinoma , ascites , ovary , cystadenocarcinoma , isoamylase , pancreatic tumor , immunoperoxidase , amylase , adenocarcinoma , ovarian cancer , cancer , immunology , antibody , pancreatic cancer , enzyme , biochemistry , chemistry , monoclonal antibody
A case of a 49‐year‐old housewife with persistent hyperamylasemia, intractable amylase‐rich ascites, and papillary serous cystadenocarcinoma of the ovaries is presented. The hyperamylasemia was attributable to neoplastic production of salivary‐type isoamylase by analysis of isoamylase in the serum, urine, ascites, primary tumor of the ovaries and metastatic tumor of the lymph nodes. Cellular localization of amylase in the tumor tissues was demonstrated immunohistochemically in the primary and metastatic tumors using an indirect immunoperoxidase method.